Across healthcare systems worldwide, laboratory testing has become one of the most critical inputs to clinical decision‑making—yet the professionals who run and validate those tests are in increasingly short supply. Medical laboratory technologists are harder to recruit, harder to retain, and under more pressure than ever, especially in primary care and rural settings where resources are already stretched.

When this “people shortage” becomes the norm rather than the exception, the question is no longer just how to fill shifts. It is whether healthcare providers can continue to deliver timely, high‑quality diagnostics and safeguard patient safety with limited lab staffing.

This is where new diagnostic models—especially AI‑enabled, all‑in‑one point‑of‑care (POC) solutions—can make a meaningful difference.

From Staffing Gap to Clinical Risk

In many laboratories, understaffing first shows up as time: turnaround times stretch, night and weekend shifts are overloaded, and backlogs become routine rather than occasional. As samples pile up, technologists have less time for repeat testing, quality control, and communication with clinicians. The probability that a small oversight turns into a reporting error inevitably increases.

In primary care clinics and remote facilities, the pressure is even stronger. Many of these sites do not have the scale or budget to run full in‑house labs. Instead, they depend on central hospital laboratories or third‑party providers. A simple CBC, kidney function panel, or inflammatory marker may involve an extra trip for the patient and a delay of days for the results.

The consequences go beyond inconvenience:

• Clinical decisions are delayed because physicians are waiting on key laboratory data.
• Follow‑up appointments multiply, increasing costs for both providers and patients.
• Patient adherence and satisfaction suffer when care stretches over multiple visits and locations.

What begins as a human resources problem gradually becomes a systemic challenge to diagnostic efficiency, continuity of care, and ultimately, patient safety.

Why Traditional Lab Models Can No Longer “Squeeze Out” More Capacity

Faced with staffing shortages, many hospitals and clinics have tried short‑term fixes: cross‑departmental support, rotating staff to cover gaps, shortening training cycles, hiring temporary or agency staff. These approaches can help in a crisis but are rarely sustainable. Over time, they increase burnout, raise the risk of errors, and erode the enthusiasm of experienced technologists.

Meanwhile, the complexity of laboratory medicine continues to grow. New tests in oncology, autoimmunity, infectious diseases, and chronic disease management are continuously introduced into routine workflows. Each new assay adds not only analytical steps but also new reagents, quality‑control processes, and interpretive requirements.

In this context, simply asking existing staff to “work faster” or “take on more” is no longer a viable strategy. What healthcare systems need is a way to:

• Bring key diagnostic capabilities closer to the point of care.
• Automate as many routine steps as possible.
• Make operation simple enough that non‑specialist staff can safely use the system under appropriate oversight.

AI‑enabled, multi‑functional POC platforms are designed precisely for this new reality.

Ozelle’s Answer: An AI Morphology‑Driven All‑in‑One Mini Lab

Founded in 2014, Ozelle is a digitally driven healthcare company focused on applying artificial intelligence (AI) and Internet of Things (IoT) technologies to make high‑quality diagnostics more accessible in primary care. Over the past decade, Ozelle has built a deep expertise in AI‑based cell morphology, combining advanced machine vision, high‑resolution optics, and large‑scale training datasets to bring microscopic‑level insight into automated analyzers.

The EHBT‑50 Minilab is Ozelle’s flagship all‑in‑one analyzer for human diagnostics. It integrates:

• 7‑part differential hematology (CBC with extended morphology),
• Immunoassay,
• Biochemistry,

all on a single compact platform. This integration is designed specifically for primary care clinics, community health centers, emergency departments, and other decentralized settings that need broad diagnostic coverage but do not have the capacity to build full‑scale laboratories.

Advanced cell morphology, powered by AI

Unlike traditional impedance‑only hematology analyzers, the EHBT‑50 is driven by AI‑enhanced cell morphology analysis. It combines imaging with deep learning algorithms to classify blood cells and flag abnormalities. Beyond basic 7‑part differentials, the system can identify multiple sub‑classes and atypical cells, such as NST, NSG, NSH, ALY, PAg, and RET, as well as abnormal forms like schistocytes, echinocytes, and teardrop cells.

This gives clinicians in resource‑limited settings access to a depth of hematological insight that traditionally required experienced morphologists and dedicated microscopy time.

How One Mini Lab Helps Relieve the Staffing Squeeze

Completing sampling, testing, and decision‑making in a single visit

The EHBT‑50 supports both capillary (finger‑stick) and venous whole blood, requiring as little as 30 µL from a fingertip for hematology testing. In a single platform, clinicians can run:

• A 7‑diff CBC with 37 parameters, including WBC, RBC, platelets, red cell indices, and extended morphology‑derived indices such as NLR and PLR.
• Key immunoassays like CRP, IL‑6, PCT, NT‑proBNP, troponin, D‑dimer, HbA1c, thyroid hormones (T3, T4, TSH), ferritin, and selected sex hormones (where available and cleared).
• Core biochemistry tests covering glucose, lipids, renal and liver function parameters (e.g., UA, UREA, ALT, AST, TB, ALB).

Throughput of up to 10 samples per hour makes the EHBT‑50 suitable for routine workloads in primary care and small hospital departments. Instead of sending patients to external labs and waiting days for results, clinicians can obtain critical lab data within the same consultation window. That enables:

• Same‑day diagnosis and treatment decisions.
• Fewer follow‑up visits just to “discuss results.”
• Reduced risk of patients dropping out of care between appointments.

For busy teams with limited technologist coverage, this kind of on‑the‑spot testing directly translates into better time use and less administrative overhead.

Lowering the operational barrier and dependence on senior technologists

The EHBT‑50 is built around single‑use test kits and a cartridge‑based workflow. The instrument automates:

• Sample aspiration,
• Mixing and staining (for hematology and morphology),
• Reaction handling (for immunoassays and biochemistry),
• Image acquisition and analysis.

Operators interact with an intuitive 10.1‑inch touch screen and follow step‑by‑step prompts. This design offers several advantages in understaffed environments:

• Simplified training: Nurses or general clinical staff can be trained to operate the system under appropriate supervision, instead of relying exclusively on highly specialized technologists.
• Maintenance‑free operation: Single‑use cartridges and a streamlined fluidic design eliminate many of the routine cleaning, de‑clogging, and calibration tasks associated with traditional analyzers, reducing downtime and engineering support needs.
• Automated morphology interpretation: AI algorithms handle much of the pattern recognition that would otherwise require experienced microscopic review, ensuring consistent quality even when senior morphologists are not on site.

The goal is not to replace skilled technologists, but to extend their reach—freeing them from repetitive tasks so they can focus on oversight, complex cases, and quality management.

One device instead of many: space, workflow, and cost efficiency

To offer comparable diagnostic coverage using conventional devices, a primary care clinic or small hospital might need:

• A standalone hematology analyzer,
• A bench‑top immunoassay system,
• A separate dry chemistry or wet biochemistry analyzer,

Each device comes with its own footprint, supply chain, training requirements, and maintenance plan. For organizations already facing staff shortages, managing this ecosystem can be as challenging as performing the tests themselves.

By contrast, the EHBT‑50 consolidates these modalities into a single 350 × 400 × 450 mm unit weighing around 15 kg. It integrates built‑in thermal printing, offers options for external printers, and communicates with LIS and HIS systems over LAN and Wi‑Fi, using standard interfaces.

This “one device, many tests” approach helps healthcare organizations:

• Optimize limited bench space.
• Reduce the number of vendors and contracts to manage.
• Simplify quality control and consumable logistics.
• Scale point‑of‑care testing to multiple sites without multiplying complexity.

Real‑World Use Cases: From Clinics to County‑Level Emergency Departments

Primary care clinics and community health centers

In community settings, clinicians must manage a wide range of conditions with limited onsite resources. An all‑in‑one Mini Lab supports:

• Infection assessment: CBC plus inflammatory markers like CRP and IL‑6 support clinical differentiation between bacterial and viral infections when interpreted in context

• Chronic disease management: Glucose, lipid, renal, and liver panels enable evidence‑based follow‑up of patients with diabetes, hypertension, and chronic kidney or liver disease.
• Screening and preventive care: Basic biochemical and hematological profiles can be integrated into routine health checks, improving early detection of anemia, metabolic disturbances, and organ dysfunction.

Instead of sending patients to external labs and asking them to return days later, clinicians can adjust therapy in real time, which improves adherence and outcomes.

County‑level hospitals and emergency or fever clinics

In county hospitals or smaller emergency departments, rapid triage and risk stratification are crucial. With the EHBT‑50, care teams can:

• Combine CBC with cardiac markers (e.g., troponin, CK‑MB, NT‑proBNP) and D‑dimer to support early triage in patients presenting with chest pain or dyspnea
• Use inflammatory markers alongside CBC to evaluate febrile patients and support decisions about admission versus outpatient management.
• Maintain essential diagnostic capacity during off‑hours or in remote satellite facilities without fully staffed central labs.

In these scenarios, the Mini Lab helps redirect the limited time of experienced technologists toward complex studies, critical value management, and oversight of multiple POC sites.

Health check‑up centers and mobile or outreach services

Occupational health providers, check‑up centers, and mobile health units often face the challenge of delivering consistent diagnostics in non‑traditional settings. The compact footprint and integrated design of the EHBT‑50 make it suitable for:

• Mobile screening programs,
• Medical alliance outreach clinics,
• Community campaigns focused on chronic disease or infectious disease control.

Results can be securely transmitted back to central systems through LIS/HIS integration, creating a complete data trail for longitudinal patient management and population‑level analysis.

Planning for Success: POC Is Powerful, but Not “Plug and Play”

Despite its advantages, any POC device must be deployed with careful planning and governance. The EHBT‑50 is designed to simplify workflows, but safe and reliable operation still depends on:

• Structured training and competency assessment Staff need standardized training in sample collection, handling, instrument operation, and basic troubleshooting. Regular competency checks and protocol refreshers help maintain performance over time.
• Robust quality control and external validation Use of QC materials, participation in proficiency testing where available, and periodic cross‑comparison with central laboratory analyzers are key to ensuring that POC results maintain laboratory‑grade accuracy.
• Thoughtful investment and ROI evaluation While the acquisition of an all‑in‑one Mini Lab is a significant capital decision for many primary care organizations, the full picture includes increased test volumes, reduced outsourcing costs, improved clinic throughput, and higher patient satisfaction. Over a realistic time horizon, these benefits can offset the initial investment and create additional value.
• Data integration and regulatory compliance By connecting the EHBT‑50 to existing LIS and HIS environments, healthcare providers can ensure that POC test results are fully traceable, auditable, and available across the care continuum. This not only supports regulatory requirements but also enables remote oversight by central lab teams and specialists.

In an Era of “People Shortage,” Let Experts Focus on What Matters Most

No matter how sophisticated AI and automation become, they cannot replace the judgment and experience of trained laboratory professionals. What they can do is reshape where and how those professionals spend their time.

With platforms like the EHBT‑50 Minilab, healthcare organizations can:

• Maintain diagnostic quality and patient safety even when lab staffing is tight.
• Free expert technologists from repetitive, manual tasks so they can concentrate on complex diagnostics, method development, and quality management.
• Expand access to reliable laboratory testing for patients in primary care, rural, and underserved regions, bringing essential diagnostics closer to where people live and receive care.

Ozelle’s AI morphology‑driven, all‑in‑one POC solutions are built for this new reality—not to replace the laboratory, but to extend its capabilities and resilience when human resources are constrained. For every technologist and every clinic striving to deliver trustworthy diagnostics in a challenging environment, the goal is the same: make it possible to do more, for more patients, without compromising on quality.

If you are exploring how to strengthen diagnostic services under staffing pressure, experiencing the EHBT‑50 in your own workflow is often the best starting point. Seeing how AI‑guided morphology and multi‑modal testing perform in your real‑world setting can reveal new ways to balance capacity, quality, and patient experience.

FAQ: AI All‑in‑One Mini Lab in Primary Care

What kinds of tests can the EHBT‑50 Minilab run?

The EHBT‑50 combines 7‑part differential hematology with a wide menu of immunoassays and biochemistry tests. On the hematology side, it delivers 37 CBC parameters, including extended indices like NLR and PLR, and can flag multiple abnormal cell types using AI‑enhanced morphology. Immunoassays cover key markers for inflammation, cardiac risk, diabetes, thyroid function, anemia, and selected hormones, while the biochemistry module supports glucose, lipids, and core renal and liver function tests.

How does the system help when experienced lab technologists are not available onsite?

The EHBT‑50 automates most pre‑analytical and analytical steps—from sample aspiration to staining, imaging, and interpretation—within single‑use test kits. Its intuitive touch‑screen interface allows trained nurses or general staff to perform routine testing, while AI algorithms

This reduces the day‑to‑day dependency on senior technologists without removing them from the oversight loop.

What sample volume and throughput can we expect in a typical clinic?

For hematology, the system requires as little as 30 µL of capillary blood from a fingertip, and can process up to 10 samples per hour under routine conditions. Immunoassay and biochemistry tests use small volumes of whole blood, serum, or plasma within the same platform, making it practical for clinics with moderate patient flow and limited phlebotomy resources.

How is quality control managed on a compact POC platform?

The EHBT‑50 supports dry‑type QC cards and automated calibration routines to stabilize performance over time. In practice, providers typically combine internal QC (daily controls, rule‑based monitoring) with periodic comparison against central lab analyzers and participation in external quality programs where available. Integrated LIS/HIS connectivity ensures that QC and patient data are fully traceable for audits and regulatory review.

Is the EHBT‑50 suitable for multi‑site or mobile deployments?

Yes. With its compact footprint, modest weight, and built‑in connectivity via LAN and Wi‑Fi, the EHBT‑50 can be deployed in community clinics, satellite emergency departments, mobile units, and outreach programs. Central laboratory teams can monitor performance and review data remotely through LIS/HIS integration, enabling consistent quality across multiple decentralized sites.

What should we consider when calculating the return on investment?

Beyond the purchase price, a realistic ROI assessment should include the reduction in outsourced testing, shorter turnaround times, lower repeat visit rates, improved clinic throughput, and the impact on patient satisfaction and retention. Because the EHBT‑50 consolidates several analyzers into one platform and uses single‑use kits with minimal maintenance, many organizations find that total cost of ownership compares favorably with traditional multi‑instrument setups—especially in settings where lab technologist time is a scarce resource.